A detailed history of Independence Bank Of Kentucky transactions in Amgen Inc stock. As of the latest transaction made, Independence Bank Of Kentucky holds 1,410 shares of AMGN stock, worth $394,729. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,410
Previous 1,555 9.32%
Holding current value
$394,729
Previous $485,000 6.39%
% of portfolio
0.1%
Previous 0.13%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

SELL
$309.38 - $337.38 $44,860 - $48,920
-145 Reduced 9.32%
1,410 $454,000
Q2 2024

Jul 25, 2024

BUY
$262.75 - $319.31 $120,865 - $146,882
460 Added 42.01%
1,555 $485,000
Q1 2024

Apr 16, 2024

SELL
$268.87 - $324.56 $16,132 - $19,473
-60 Reduced 5.19%
1,095 $311,000
Q4 2023

Jan 23, 2024

SELL
$255.7 - $288.46 $5,114 - $5,769
-20 Reduced 1.7%
1,155 $332,000
Q3 2023

Oct 16, 2023

SELL
$218.65 - $271.46 $27,331 - $33,932
-125 Reduced 9.62%
1,175 $315,000
Q2 2023

Jul 07, 2023

SELL
$214.27 - $253.37 $5,356 - $6,334
-25 Reduced 1.89%
1,300 $288,000
Q1 2023

Apr 06, 2023

BUY
$225.79 - $275.2 $33,868 - $41,280
150 Added 12.77%
1,325 $320,000
Q4 2022

Jan 09, 2023

SELL
$229.03 - $291.01 $73,289 - $93,123
-320 Reduced 21.4%
1,175 $309,000
Q3 2022

Oct 06, 2022

SELL
$224.46 - $253.15 $47,136 - $53,161
-210 Reduced 12.32%
1,495 $337,000
Q2 2022

Jul 06, 2022

SELL
$230.71 - $256.74 $34,606 - $38,511
-150 Reduced 8.09%
1,705 $415,000
Q1 2022

Apr 14, 2022

SELL
$219.27 - $242.57 $58,106 - $64,281
-265 Reduced 12.5%
1,855 $449,000
Q4 2021

Jan 26, 2022

BUY
$198.88 - $227.6 $7,955 - $9,104
40 Added 1.92%
2,120 $477,000
Q3 2021

Oct 26, 2021

BUY
$212.27 - $248.7 $52,006 - $60,931
245 Added 13.35%
2,080 $442,000
Q2 2021

Jul 23, 2021

SELL
$233.58 - $259.14 $22,190 - $24,618
-95 Reduced 4.92%
1,835 $447,000
Q1 2021

Apr 21, 2021

BUY
$221.91 - $258.6 $55,477 - $64,650
250 Added 14.88%
1,930 $480,000
Q4 2020

Jan 22, 2021

BUY
$216.38 - $257.67 $11,684 - $13,914
54 Added 3.32%
1,680 $386,000
Q3 2020

Oct 05, 2020

BUY
$234.65 - $260.95 $1,407 - $1,565
6 Added 0.37%
1,626 $413,000
Q2 2020

Jul 08, 2020

SELL
$197.81 - $242.74 $4,945 - $6,068
-25 Reduced 1.52%
1,620 $382,000
Q3 2019

Oct 21, 2019

BUY
$174.11 - $208.62 $9,576 - $11,474
55 Added 3.46%
1,645 $318,000
Q2 2019

Jul 23, 2019

BUY
$166.7 - $195.41 $25,005 - $29,311
150 Added 10.42%
1,590 $293,000
Q1 2019

Apr 29, 2019

BUY
$180.87 - $203.88 $21,704 - $24,465
120 Added 9.09%
1,440 $274,000
Q3 2018

Oct 17, 2018

BUY
$185.29 - $208.89 $12,785 - $14,413
69 Added 5.52%
1,320 $274,000
Q2 2018

Aug 07, 2018

SELL
$166.05 - $186.51 $2,988 - $3,357
-18 Reduced 1.42%
1,251 $231,000
Q1 2018

Apr 18, 2018

SELL
$169.43 - $198.0 $4,235 - $4,950
-25 Reduced 1.93%
1,269 $216,000
Q4 2017

Feb 08, 2018

BUY
$168.79 - $188.59 $218,414 - $244,035
1,294
1,294 $225,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Independence Bank Of Kentucky Portfolio

Follow Independence Bank Of Kentucky and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Independence Bank Of Kentucky, based on Form 13F filings with the SEC.

News

Stay updated on Independence Bank Of Kentucky with notifications on news.